Manufacturer high quality Cefsulodine sodium Cas 52152-93-9 with good price CAS NO.52152-93-9

Wuhan Fortuna Chemical Co.,Ltd is a professional integrative chemical enterprise with 18 years exporting experience,which is being engaged in Pharmaceutical and its intermediates, Food and Feed additives, Fine chemicals.

Cefsulodin Sodium Salt: An Overview

1. Drug Class:
Cefsulodin is a third-generation cephalosporin antibiotic, specifically a monobactam-related cephalosporin. It is administered intravenously (IV) or intramuscularly (IM) due to its poor oral bioavailability. The sodium salt form enhances its solubility for parenteral use.

2. Mechanism of Action:
Like other β-lactams, it inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death.

3. Spectrum of Activity:

• Narrow-spectrum, with strong anti-pseudomonal activity:

  • Targets Pseudomonas aeruginosa (including some multidrug-resistant strains).

  • Limited activity against other Gram-negative bacteria (e.g., Escherichia coli, Klebsiella).

  • Weak or no activity against Gram-positive bacteria (e.g., Staphylococcus aureus, Streptococcus spp.).

4. Clinical Indications:

• Primarily used for severe Pseudomonas infections:

  • Hospital-acquired pneumonia.

  • Complicated urinary tract infections (UTIs).

  • Sepsis or bacteremia caused by P. aeruginosa.

• Occasionally used in cystic fibrosis patients for respiratory infections.

5. Pharmacokinetics:

• Administration: IV/IM only (no oral form).

• Half-life: ~1.5–2 hours, requiring multiple daily doses.

• Excretion: Mainly renal; requires dose adjustment in renal impairment.

6. Resistance Concerns:

• Pseudomonas may develop resistance via:

  • Production of β-lactamases (e.g., AmpC).

  • Efflux pumps or altered PBPs.

• Often used in combination with aminoglycosides (e.g., tobramycin) for synergistic effects.

7. Side Effects:

• Common: Injection-site reactions, rash, diarrhea.

• Rare but serious:

  • Hypersensitivity (cross-reactivity risk in penicillin-allergic patients).

  • Clostridioides difficile infection.

  • Transient liver enzyme elevations.

8. Contraindications:

• Hypersensitivity to cephalosporins or β-lactams.

• Severe renal dysfunction without dose adjustment.

9. Historical & Regional Use:

• More commonly used in Japan and some European countries.

• Less frequently prescribed in the U.S. due to newer anti-pseudomonal agents (e.g., ceftazidime, cefepime).

10. Research Applications:

• Used in microbiology labs as a selective agent to isolate or study Pseudomonas aeruginosa.

Key Takeaway:
Cefsulodin sodium salt is a niche cephalosporin with targeted activity against Pseudomonas aeruginosa. Its use is reserved for severe infections caused by this pathogen, often in combination therapies to mitigate resistance. Limited adoption in some regions reflects the availability of broader-spectrum alternatives.